HYPD · Hyperion Defi, Inc. · Executive Compensation
Market Cap
$54.23M
Shares
15.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Rowe | Former Chief Executive Officer | $807,756 |
| Bren Kern | Former Chief Operating Officer | $507,364 |
| David Knox | Chief Financial Officer | — |
| Hyunsu Jung | Chief Executive Officer / Chief Investment Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael Rowe | Chief Executive Officer | $775,468 |
| John Gandolfo | Chief Financial Officer | $685,454 |
| Bren Kern | Chief Operating Officer | $566,985 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael Rowe | Chief Executive Officer | $1,333,510 |
| Tsontcho Ianchulev | Former Chief Executive Officer and Chief Medical Officer | $732,383 |
| John Gandolfo | Chief Financial Officer | $651,288 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Tsontcho Ianchulev | Former Chief Executive Officer and Chief Medical Officer | $1,511,184 |
| Michael Rowe | Chief Executive Officer | $1,172,579 |
| John Gandolfo | Chief Financial Officer | $1,126,252 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Tsontcho Ianchulev | Chief Executive Officer and Chief Medical Officer | $1,330,313 |
| John Gandolfo | Chief Financial Officer | $746,910 |
| Michael Rowe | Chief Operating Officer | $665,233 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Tsontcho Ianchulev | Chief Executive Officer and Chief Medical Officer | $1,247,138 |
| John Gandolfo | Chief Financial Officer | $653,635 |
| Michael Rowe | Chief Operating Officer | $481,833 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Tsontcho Ianchulev | Chief Executive Officer and Chief Medical Officer | $1,397,350 |
| John Gandolfo | Chief Financial Officer | $1,161,542 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Rubenstein | General Counsel | Appointed | 2026-07-08 |
| Robert Rubenstein | General Counsel | Appointed | 2026-01-05 |
| Hyunsu Jung | Chief Executive Officer | Appointed | 2026-01-05 |
| Robert Rubenstein, Esq. | General Counsel | Appointed | 2026-01-05 |
| Hyunsu Jung | Chief Executive Officer | Appointed | 2026-01-05 |
| Michael Rowe | chief executive officer | Resigned | 2025-10-31 |
| Michael Rowe | member of the Board of Directors | Resigned | 2025-10-02 |
| David Knox | Treasurer | Appointed | 2025-09-29 |
| David Knox | Chief Financial Officer | Appointed | 2025-09-29 |
| Happy Walters | member of the Board | Appointed | 2025-09-08 |
| Max Fiege | Strategic Advisor | Appointed | 2025-06-24 |
| Hyunsu Jung | Chief Investment Officer | Appointed | 2025-06-24 |
| Hyunsu Jung | Chief Investment Officer | Appointed | 2025-06-24 |
| Hyunsu Jung | serve on its Board of Directors | Appointed | 2025-06-24 |
| Ram Palanki, Pharm. D. | Board | Resigned | 2025-06-24 |
| Sean Ianchulev, M.D. | Board | Resigned | 2025-06-24 |
| Charles Mather IV | Board | Resigned | 2025-06-24 |
| Charles Mather IV | Chair | Resigned | 2025-06-24 |
| Hyunsu Jung | director | Appointed | 2025-06-24 |
| Hyunsu Jung | Chief Investment Officer | Appointed | 2025-06-24 |
| Michael Rowe | Principal Financial Officer, Treasurer and Secretary | Appointed | 2024-11-25 |
| Andrew D. Jones | Chief Financial Officer | Appointed | 2024-09-03 |
| John Gandolfo | Chief Financial Officer | Retired | 2024-09-03 |